browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
b8891d59-2d0a-4d22-af4d-c76e32d26873
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 18:06:17
Income (reported)
$8,000
Expenses (reported)
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

CAROL G HOLLADAY & ASSOCIATES

federal consulting, lobbying, business development

Contact
CAROL GRAVES HOLLADAY
Phone
+1 202-669-7039
Address
zip:20003, city:Washington, state:DC, street:507 Independence Ave SE
Client

PHARMADVA

manufacturing & distribution medical device contracted through prosthetics in VA Med Ctrs

State
NY
Country
US
Effective date
2025-06-02
Issues lobbied + lobbyists (1)

VET — Veterans

Congressional Meetings to introduce PharmAdva's Medacube to Members of Congress and their staffs. Buy American issues and tariff increases in China. Medacube has 2 small components made in China and is trying to move manufacturing those components to US. HR 2148 - Veteran Caregiver Reeducation, Reemployment, and Retirement Act, meeting to support with Cong. Bergman (MI). S. 1874 -Title VIII Nursing Workforce Reauthorization Act of 2025 reauthorizes through FY2026 and revises various programs and activities of the Centers for Medicare & Medicaid Services - communicated support with NY, WY, FL, and TN Delegations. VA Meetings with VISNs Home-Based Primary Care Departments, Meetings with NY Delegation to support research base in Rochester and relocating manufacturing of some components to US. Meeting with Congresswoman Tenney staff to discuss SBIR funding and support of NIA grant application.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE; Veterans Affairs, Dept of (VA)

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.